ID6 Cost-Effectiveness of Liposomal Daunorubicin Versus Liposomal Doxorubicin in Kaposi Sarcoma
May 1, 1998, 00:00
10.1046/j.1524-4733.1998.1100376.x
https://www.valueinhealthjournal.com/article/S1098-3015(10)75613-8/fulltext
Title :
ID6 Cost-Effectiveness of Liposomal Daunorubicin Versus Liposomal Doxorubicin in Kaposi Sarcoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75613-8&doi=10.1046/j.1524-4733.1998.1100376.x
First page :
Section Title :
Open access? :
No
Section Order :
35